Evidence map›Paper›PMID 30800309›Full record

ArticleSAGE open medical case reports2019

Gastric mixed adenoneuroendocrine carcinoma case report.

Miguel Angel Moyón Constante, Fernando Xavier Moyón Constante, Jorge Fernando Tufiño, Andres Cárdenas Patiño, Gabriel Alejandro Molina, Bernardo Miguel Gutierrez

Abstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miguel Angel Moyón ConstanteDepartment of General Surgery, Instituto Ecuatoriano de Seguridad Social (IESS), Quito, Ecuador.
Fernando Xavier Moyón ConstanteDepartment of General Surgery, Instituto Ecuatoriano de Seguridad Social (IESS), Quito, Ecuador.
Jorge Fernando TufiñoDepartment of General Surgery, Instituto Ecuatoriano de Seguridad Social (IESS), Quito, Ecuador.
Andres Cárdenas PatiñoDepartment of General Surgery, Instituto Ecuatoriano de Seguridad Social (IESS), Quito, Ecuador.
Gabriel Alejandro MolinaPGY4 General Surgery Resident, Pontificia Universidad Católica del Ecuador (PUCE), Quito, Ecuador.ORCID https://orcid.org/0000-0003-0001-9070
Bernardo Miguel GutierrezCollege of Biological and Environmental Sciences, Universidad San Francisco de Quito, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mixed adenoneuroendocrine carcinomas are rare tumors that contain both an exocrine and an endocrine component. Since the latest classification by the World Health Organization and with the aid of immunostaining, more mixed adenoneuroendocrine carcinomas are now identified and diagnosed. Nonetheless, our knowledge of these tumors is still limited, notably concerning gastric variants, as the cases reported in the literature are very limited. The clinical and surgical treatment, including the chemotherapy schemes, the prognosis, and recurrence still represent challenges for the medical teams. We present the case of a 62-year-old woman. After an upper endoscopy revealed multiple polyps and a low-grade neuroendocrine tumor, a D2 radical gastrectomy was performed. A low output esophageal anastomotic leak was discovered in the postoperative period and successfully managed. Pathology revealed a gastric mixed adenoneuroendocrine carcinoma, the first case of this kind reported in Ecuador. Patient is doing well and under constant surveillance up until her 13th postoperative month.

Indexed as

Gastric cancermixed adenoneuroendocrine carcinoma

Identifiers

PMID30800309
PMCPMC6378457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.